Tianjin Huairen Pharmaceutical Co., Ltd. (Huairen) founded in 1996, is located in Tianjin Xiqing Economic Development Zone. It is a modern pharmaceutical enterprise integrating scientific R&D, production and sales. It is awarded the title of High and New Technology Enterprise and is recognized as High-tech SMEs by Tianjin Municipal Science and Technology Bureau.

Since its establishment, the company has been adhering to the business philosophy of "quality first, reputation first" and committed to becoming a professional chronic disease drug manufacturer in China. Over the years, the qualified rate of market sampling has reached 100%, which has a good reputation in the industry. It has been honored by the Tianjin Administration for Market Regulation as "A-level enterprise for quantitative grade and classified management of drug production", "reassuring pharmaceutical manufacturer" and other titles. Since its development, the company has mainly produced APIs, tablets, capsules, granules and other dosage forms.

Main products: Telmisartan, Iron Dextra, Irbesartan Hydrochlorothiazide, Gliclazide Modified, Simvastatin and other varieties.